A Patient Navigator Intervention

This project, a partnership with pharmaceutical company Pfizer, Inc., is developing a theory-based, in-clinic component to improve breast and cervical cancer outcomes by helping Hispanic/Latina patients “navigate” the many health care choices and actions they have to address screening abnormalities. Using qualitative and quantitative methods and comparison, as well as treatment sites, the study will monitor and evaluate critical elements of healthcare access that occur during treatment and the first 12 months of survivorship, starting at diagnosis.

Principle Investigators

Amelie G. Ramirez, DrPH IHPR, The University of Texas Health Science Center at San Antonio

Collaborations

The University of Texas Health Science Center at San Antonio University Health System University Family Health Center Drs. April Hain and Teresa Ruiz, Clinic Medical Directors Dr. Priti Mody-Bailey, CEO of Community Medicine Associates Maria Falkenberg, MSN, RNC, Nurse Practitioner Dr. Pam Otto, Medical Director, UT Mammography Services Dr. Robert Schenken, Medical Director, UT OB/GYN Services Dr. Donald Dudley, Principal Investigator for San Antonio site of NCI-funded PNRP The National Cancer Institute The American Cancer Society

Location

Two community clinics, part of the University Family Health Center and managed by The University of Texas Health Science Center at San Antonio, in a low-income Hispanic barrio in South San Antonio.

Conclusions

The study, which began implementation in March 2006, has recruited more than 90 women thus far, nearing its recruitment goal of 58 in an intervention group and 58 in a control group. In the end, the result is expected to be a model of cancer care that can be replicated and disseminated in other communities where Hispanic women confront significant disparities in cancer health care delivery. The proposed breast and cervical cancer patient navigator program represents a new area of research that is being actively promoted by the NCI and CDC, and it complements Pfizer’s concept of a research-anchored foundation of care that identifies barriers to care that lead to interventions that improve health outcomes.

Abstracts

Ramirez, AG, Tolcher, A, Miller, AR, Gallion, K, and San Miguel de Majors, SL. Evaluating the efficacy of a patient navigator program with Hispanic patients from community clinics. Abstract 109085: 133rd Annual American Public Health Association, Philadelphia, 2005.